Braidwell LP Nevro Corp Transaction History

Braidwell LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$7.96 - $13.59 $617,696 - $1.05 Million	-77,600 Reduced 4.37%	1,698,768 $14.3 Billion
Q2 2023 Aug 14, 2023	BUY	$22.62 - $39.32 $3.24 Million - $5.64 Million	143,453 Added 8.79%	1,776,368 $45.2 Billion
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $13.3 Million - $18.1 Million	440,617 Added 36.96%	1,632,915 $59 Billion
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $43.4 Million - $58.9 Million	1,192,298 New	1,192,298 $47.2 Billion

6.52M

50K

150K

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $207M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

Stay updated on Braidwell LP with notifications on news.